Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1314 results for "hiv"

Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection
Aidsmap

Gilead reports phase 3 results for once-a daily single tablet ...

Gilead Sciences, announced detailed 48-week results from two phase 3 studies (Studies 104 and 111) evaluating its investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in ... PharmaBiz, 28 minutes ago
[x]  

2,060 images for hiv

The Guardian Express, 1 day ago
Monthly Prescribing Reference, 1 day ago
Manica Post, 1 day ago
Bio Spectrum Asia, 1 day ago
22 WSBT, 7 hours ago
Medical News Today, 13 minutes ago
Monthly Prescribing Reference, 1 day ago
Times of India, 2 days ago
FOX 59, 8 hours ago
Sify, 1 day ago
VOA News

U.S. Push for Abstinence in Africa Is Seen as Failure Against H.I.V.

Mining Industry News and Mining press releases from public and private companies. Mining Newswire accepts press releases and headline news. Unlimited Mass Media SEO Press Release Distribution with Guaranteed Results U.S. National Distribution. ...
 Africa News Wire1 day ago HIV Prevention Trials Show Flexibility in Antiretroviral Dosing  VOA News9 hours ago

HIV Therapeutic Specialist

Vacancy summary Company: Star Position: HIV Therapeutic Specialist Category: Hospital Specialist Region: East Midlands Location: East Midlands, England Reference: 1501 - 161 ...
 Pharma Field3 hours ago

Friday Round up: Financial Services for the Poor, India's Budget, Worldwide Nutrition, HIV/AIDS and Behavior, Basu to deliver Amartya Sen lecture

Microcredit has been both praised and criticized as a development tool. In a Financial Services for the Poor conference hosted by CGAP, IPA, J-PAL, and the World Bank, researchers, practitioners, and thought leaders examine and discuss the lessons ...
 World Bank7 hours ago

UNAIDS Hails Nigeria's Signing Of HIV Anti-Discrimination Law

AHEAD of the World Zero Discrimination Day tomorrow, the Joint United Nations Programme on AIDS (UNAIDS) has expressed full support of the Federal Government of Nigeria for her commitment towards ending stigma and discrimination against people ...
 The Guardian Nigeria8 hours ago

Accepting Our Boys, Uplifting Our Men: Loving Unconditionally to End the Spread of HIV/AIDS

By sending the message that our young black gay males are not acceptable, we contribute to our boys, sons, brothers and men accounting for the highest rate of new HIV infections, and reduce the rate of survival among those we call family. Love and ...
 Huffington Post9 hours ago

Bristol-Myers Squibb Co Daclatasvir/Sovaldi Combo Cured 97% In HIV-HCV Study

Bristol-Myers Squibb Co ( NYSE:BMY ) announced Thursday positive results for its drug daclatasvir, used in combination with Gilead Sciences, Inc.'s ( NASDAQ:GILD ) Sovaldi, to treat patients with chronic hepatitis C virus (HCV) co-infected with HIV, ...
 Bidness Etc19 hours ago Bristol-Myers: Drug combo cured hepatitis C in 97% with HIV  Yahoo! UK and Ireland1 day ago
[x]  
The Freepress Journal

Scientists hail daily pill that protects against HIV

London A daily pill that can dramatically cut a person's risk of contracting HIV must be made available through the UK's NHS as soon as possible, campaigners have said. Results of a major UK trial of pre-exposure prophylaxis (PrEP) have been ...
 IOL17 hours ago Brits Demand 'Game Changer' HIV Pill Be Made Available Through NHS  Sputnik2 days ago New 'game-changing' daily pill can cut HIV risk among gay men by 86pc  Business Standard3 days ago New `game-changing` daily pill can cut HIV risk among gay men by 86%  ZeeNews.com2 days ago
[x]  
Med India

Gilead's Replacement HIV Drug Improves Kidney Effects in Study

(Bloomberg) -- Gilead Sciences Inc.'s next-generation HIV drug, called TAF, was safe for patients with mild to moderate kidney impairment, a study found, bettering the treatment's chances of replacing a current standard therapy. In a study of 242 ...
 Bloomberg23 hours ago Strides Arcolab Inks Deal With Gilead Sciences for HIV Drug  Med India1 month ago Strides Arcolab inks licensing pact for Gilead's HIV drug  Business Standard1 month ago Strides Arcolab, Gilead join hands for marketing HIV drugs  Business Standard1 month ago
[x]  
Channel NewsAsia

Ebola halts HIV progress in Sierra Leone, says UN - TRFN

By Misha Hussain DAKAR, Feb 27 (Thomson Reuters Foundation) - The West African Ebola outbreak has halted progress in tackling HIV in Sierra Leone, shutting health clinics and scaring patients from being tested or seeking treatment, the ...
 Reuters Africa17 hours ago REUTERS - Ebola halts HIV progress in Sierra Leone, says UN - TRFN  Namibia Press Agency16 hours ago Ebola Virus Is Mutating  MSN India4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hiv
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less